MANE logo

MANE
Veradermics Inc

81
Mkt Cap
$2.38B
Volume
350,330.00
52W High
$69.41
52W Low
$17.00
Price
$56.71
MANE Fundamentals
Prev Close
$63.82
Open
$63.81
50D MA
$50.49
Beta
0.00
Avg. Volume
426,864.42
EPS (Annual)
-$2.23
P/B
-19.69
Rev/Employee
$0.00
Loading...
Loading...
News
all
press releases
Squawk Pod: OpenAI's eye-popping raise & hair today, hair forever - 04/01/26 Audio Only
OpenAI has closed a $122 billion funding round, bringing its valuation to $852 billion. Investor Cathie Wood discusses her bets on AI and the future of tech investing. Nike reported a struggle in the...
CNBC Television-YouTube·6d ago
News Placeholder
More News
News Placeholder
Veradermics Stock Falls 8% After Reporting Wider Loss In Q4, FY25
(RTTNews) - Shares of Veradermics, Incorporated (MANE) are moving down about 8 percent on Monday morning trading after reporting a wider loss in the fourth quarter and full year financial results...
Nasdaq News: Markets·8d ago
News Placeholder
Veradermics Reports Fourth Quarter and Full Year 2025 Financial Results and Highlights Recent Corporate and Clinical Updates
Veradermics, Incorporated (NYSE: MANE), a dermatologist-founded, late clinical-stage biopharmaceutical company focused on developing innovative therapeutics for common aesthetic and dermatological...
Business Wire·8d ago
News Placeholder
MANE (NYSE:MANE) Receives Consensus Recommendation of "Moderate Buy" from Analysts
MANE (NYSE:MANE - Get Free Report) has received a consensus recommendation of "Moderate Buy" from the five ratings firms that are presently covering the firm, MarketBeat reports. One equities...
MarketBeat·9d ago
News Placeholder
Veradermics Announces Presentations on VDPHL01 and Patient Experiences With Pattern Hair Loss at 2026 American Academy of Dermatology Annual Meeting
Veradermics, Incorporated (NYSE: MANE), a dermatologist-founded, late clinical-stage biopharmaceutical company focused on developing innovative therapeutics for common aesthetic and dermatological...
Business Wire·20d ago
News Placeholder
MANE's (NYSE:MANE) Quiet Period Will Expire on March 16th
MANE's (NYSE:MANE - Get Free Report) quiet period will end on Monday, March 16th. MANE had issued 15,077,647 shares in its IPO on February 4th. The total size of the offering was $256,319,999 based...
MarketBeat·30d ago
News Placeholder
MANE (NYSE:MANE) Receives Consensus Recommendation of "Moderate Buy" from Brokerages
Shares of MANE (NYSE:MANE - Get Free Report) have received an average recommendation of "Moderate Buy" from the five research firms that are covering the firm, MarketBeat reports. One investment...
MarketBeat·1mo ago
News Placeholder
MANE (NYSE:MANE) Upgraded by Zacks Research to "Hold" Rating
Zacks Research upgraded shares of MANE to a "hold" rating in a research report on Tuesday...
MarketBeat·1mo ago
News Placeholder
Veradermics to Participate in Upcoming March Investor Conferences
Veradermics, Incorporated (NYSE: MANE), a dermatologist-founded, late clinical-stage biopharmaceutical company focused on developing innovative therapeutics for common aesthetic and dermatological...
Business Wire·1mo ago
News Placeholder
Jefferies Financial Group Upgrades MANE (NYSE:MANE) to Strong-Buy
Jefferies Financial Group upgraded shares of MANE to a "strong-buy" rating in a report on Monday...
MarketBeat·1mo ago
<
1
2
...
>

Latest MANE News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.